The MyBody-X Longevity Test combines DNA analysis with biomarker measurements (e.g., vitamin D, homocysteine) and microbiome data to provide insights into aging. The concept is promising: genetic variants like MTHFR can influence homocysteine levels, which are linked to cardiovascular risk. However, evidence for direct lifespan extension from such tests is weak – these are mechanistic associations, not clinically validated predictors. The test can serve as a general orientation but does not replace medical diagnostics. Many parameters (e.g., vitamin D) are modifiable through lifestyle, yet individual responses vary. Long-term studies showing that recommended interventions actually extend lifespan are lacking. Safety note: Do not base medical decisions solely on test results; consult a doctor for abnormal values. Evidence: marketing/mixed.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-8e5e1a42ab73884bd8f23a86